Novo Nordisk Inc. et al v. Orbicular Pharmaceutical Technologies Pvt. Ltd.
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Orbicular Pharmaceutical Technologies Pvt. Ltd.
Case Number: 1:2022cv00856
Filed: June 24, 2022
Court: US District Court for the District of Delaware
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on June 24, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
June 24, 2022 Filing 6 Summons Issued as to Orbicular Pharmaceutical Technologies Pvt. Ltd. on 6/24/2022. (twk)
June 24, 2022 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo A/S for Novo Nordisk A/S; Corporate Parent Novo Nordisk US Holdings, Inc. for Novo Nordisk Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc. (twk)
June 24, 2022 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,762,994 B2; 8,114,833 B2; 8,579,869 B2; 8,684,969 B2; 8,920,383 B2; 9,108,002 B2; 9,132,239 B2; 9,457,154 B2; 9,616,180 B2; 9,687,611 B2; 9,775,953 B2; 9,861,757 B2; 10,220,155 B2; 10,357,616 B2; 10,376,652 B2; 11,097,063 B2; 11,311,679 B2; RE46,363 E. (twk)
June 24, 2022 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 14, 2022. Date of Expiration of Patent: See attached. Thirty Month Stay Deadline: 11/14/2024. (twk)
June 24, 2022 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk)
June 24, 2022 Filing 1 COMPLAINT filed against Orbicular Pharmaceutical Technologies Pvt. Ltd. ( Filing fee $ 402, receipt number ADEDC-3903411.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: #1 Exhibit A-R, #2 Civil Cover Sheet)(twk)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Novo Nordisk Inc. et al v. Orbicular Pharmaceutical Technologies Pvt. Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novo Nordisk Inc.
Represented By: Jack B. Blumenfeld
Represented By: Brian P. Egan
Represented By: Travis J Murray
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novo Nordisk A/S
Represented By: Jack B. Blumenfeld
Represented By: Brian P. Egan
Represented By: Travis J Murray
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Orbicular Pharmaceutical Technologies Pvt. Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?